Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE: 300702)
China
· Delayed Price · Currency is CNY 16.36
-0.04 (-0.24%)
Jan 3, 2025, 1:19 PM CST
Zhejiang Tianyu Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 43.68 | 27.36 | -118.87 | 204.68 | 667.06 | 585.73 | Upgrade
|
| Depreciation & Amortization | 304.42 | 304.42 | 254.94 | 193.42 | 136.1 | 101.18 | Upgrade
|
| Other Amortization | 2.43 | 2.43 | 1.04 | 0.56 | 0.66 | 3.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.02 | -0.06 | -0.21 | 0.65 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.09 | 2.09 | 8.21 | 46.49 | 17.15 | 18.22 | Upgrade
|
| Loss (Gain) From Sale of Investments | 62.69 | 62.69 | 59.65 | -52.72 | -68.37 | -1.28 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.3 | 6.3 | -3.87 | - | - | - | Upgrade
|
| Other Operating Activities | 634.02 | 181.3 | 92.4 | 26.91 | 40.65 | 6.92 | Upgrade
|
| Change in Accounts Receivable | -242.68 | -242.68 | -269.46 | -315.07 | -326.32 | -82.41 | Upgrade
|
| Change in Inventory | -12.72 | -12.72 | -515.15 | -763.47 | -140.19 | -283.55 | Upgrade
|
| Change in Accounts Payable | -340.18 | -340.18 | 450.23 | 355.46 | 275.12 | 53.28 | Upgrade
|
| Change in Other Net Operating Assets | -34.67 | -34.67 | -2.46 | 40.51 | 14.86 | 21.99 | Upgrade
|
| Operating Cash Flow | 425.14 | -43.9 | -48.7 | -262.23 | 622.18 | 427.84 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 45.42% | 444.51% | Upgrade
|
| Capital Expenditures | -186.53 | -316.81 | -527.01 | -736.39 | -506.05 | -354.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.75 | 3.56 | 4.11 | 0.77 | 0.74 | 0.87 | Upgrade
|
| Cash Acquisitions | 0.35 | 0.35 | - | -5.64 | -37.7 | -8.36 | Upgrade
|
| Investment in Securities | -21.55 | 2.5 | 22.5 | -118.7 | 13.88 | 208.02 | Upgrade
|
| Other Investing Activities | -49.7 | -44.95 | -20.42 | 57.59 | 11.83 | -6.12 | Upgrade
|
| Investing Cash Flow | -254.67 | -355.35 | -520.82 | -802.37 | -517.3 | -159.69 | Upgrade
|
| Long-Term Debt Issued | - | 2,184 | 1,409 | 837.47 | 465.08 | 378.07 | Upgrade
|
| Total Debt Issued | 2,067 | 2,184 | 1,409 | 837.47 | 465.08 | 378.07 | Upgrade
|
| Long-Term Debt Repaid | - | -1,679 | -752.92 | -495.14 | -255.59 | -810.07 | Upgrade
|
| Total Debt Repaid | -2,122 | -1,679 | -752.92 | -495.14 | -255.59 | -810.07 | Upgrade
|
| Net Debt Issued (Repaid) | -54.76 | 504.79 | 656.52 | 342.33 | 209.49 | -432 | Upgrade
|
| Issuance of Common Stock | 13.04 | - | - | - | 895.75 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -58 | -0.24 | - | - | Upgrade
|
| Common Dividends Paid | -75.6 | -51.12 | -69.42 | -112.43 | -94.94 | -39.66 | Upgrade
|
| Other Financing Activities | -36.1 | -90.32 | -9.76 | - | 0.2 | 2.93 | Upgrade
|
| Financing Cash Flow | -153.42 | 363.35 | 519.34 | 229.67 | 1,011 | -468.74 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.45 | -1.89 | 12.93 | -6.15 | -20.53 | 3.98 | Upgrade
|
| Net Cash Flow | 21.5 | -37.79 | -37.25 | -841.09 | 1,095 | -196.62 | Upgrade
|
| Free Cash Flow | 238.62 | -360.71 | -575.71 | -998.62 | 116.13 | 73.73 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 57.49% | - | Upgrade
|
| Free Cash Flow Margin | 9.20% | -14.27% | -21.59% | -39.24% | 4.49% | 3.49% | Upgrade
|
| Free Cash Flow Per Share | 0.68 | -1.05 | -1.65 | -2.88 | 0.36 | 0.23 | Upgrade
|
| Cash Income Tax Paid | - | -32.25 | -286.68 | -54.41 | -21.79 | 100.13 | Upgrade
|
| Levered Free Cash Flow | 293.07 | -536.35 | -415.35 | -747.26 | 141.39 | -81.75 | Upgrade
|
| Unlevered Free Cash Flow | 327.79 | -505.16 | -394.2 | -737.06 | 144.15 | -74.13 | Upgrade
|
| Change in Net Working Capital | -184.16 | 551.68 | 71.46 | 341.38 | -56.94 | 259.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.